Engler Robert

Insider Buys Quantity –
5
2014-08-14SaleHalozyme Therapeutics, Inc.
HALO
director
35,000
0.0282%
$9.96$348,726+45.74%
2014-05-15SaleHalozyme Therapeutics, Inc.
HALO
director
126,700
0.1011%
$7.56$957,991+27.15%
2012-11-29PurchaseHalozyme Therapeutics, Inc.
HALO
director
15,000
0.013%
$5.57$83,550+23.56%
2011-11-14PurchaseHalozyme Therapeutics, Inc.
HALO
director
5,000
0.0047%
$8.15$40,750+5.67%
2008-12-16PurchaseHalozyme Therapeutics, Inc.
HALO
director
10,000
0.0111%
$4.38$43,800+31.97%
2007-03-15SaleHalozyme Therapeutics, Inc.
HALO
director
50,000
0.0693%
$8.05$402,662+4.04%
2005-05-24PurchaseHalozyme Therapeutics, Inc.
HALO
director
50,000
0.0998%
$1.95$97,712-1.28%
2004-08-18PurchaseHalozyme Therapeutics, Inc.
HALO
director
20,000
0.0502%
$1.60$32,000+18.01%